Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.
暂无分享,去创建一个
[1] Young Kil Park,et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. , 2009, American journal of respiratory and critical care medicine.
[2] W. Gill,et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages , 2007, Scandinavian journal of infectious diseases.
[3] Robert Horsburgh,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.
[4] P. Kao,et al. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series , 2007, BMC pulmonary medicine.
[5] Gynecologists. ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis. , 2005, Obstetrics and gynecology.
[6] John D. Mitchell,et al. Completion pneumonectomy for chronic mycobacterial disease. , 2005, The Journal of thoracic and cardiovascular surgery.
[7] A. Humar,et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] Yong Soo Choi,et al. Surgical Treatment of Pulmonary Diseases Due to Nontuberculous Mycobacteria , 2008, Journal of Korean medical science.
[9] S. Conlan,et al. Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii , 2009, Journal of Clinical Microbiology.
[10] E. Picard,et al. Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel , 2008, Emerging infectious diseases.
[11] Ji‐Hyun Lee,et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[12] Young Kil Park,et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. , 2011, American journal of respiratory and critical care medicine.
[13] R. Wallace,,et al. A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2008, Antimicrobial Agents and Chemotherapy.
[14] T. Byrd,et al. Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria , 2008, Antimicrobial Agents and Chemotherapy.
[15] L. García-Agudo,et al. [Infections due to rapidly growing mycobacteria]. , 2012, Enfermedades infecciosas y microbiologia clinica.
[16] S. Field,et al. Mycobacterium avium complex pulmonary disease in patients without HIV infection. , 2004, Chest.
[17] D. van Soolingen,et al. Nontuberculous Mycobacteria, Zambia , 2009, Emerging infectious diseases.
[18] K. Lee,et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. , 2007, Chest.
[19] C. Yi,et al. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. , 2003, AJR. American journal of roentgenology.
[20] F. Serres. Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency: Summary of an Analysis of Published Genetic Epidemiologic Surveys , 2002 .
[21] R. Wallace,,et al. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. , 1993, The American review of respiratory disease.
[22] John D. Mitchell,et al. Anatomic lung resection for nontuberculous mycobacterial disease. , 2008, The Annals of thoracic surgery.
[23] R. Kolter,et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. , 2006, Microbiology.
[24] D. Griffith. Clinical features of disease caused by rapidly growing mycobacteria , 1993 .
[25] R. Wallace,,et al. Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria , 2002, Clinical Microbiology Reviews.
[26] C. Daley,et al. Pulmonary disease caused by rapidly growing mycobacteria. , 2002, Clinics in chest medicine.
[27] ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. , 2011, Obstetrics and gynecology.
[28] M. Chung,et al. Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection , 2005, Journal of Korean medical science.
[29] N. Takahashi,et al. Pneumonectomy for nontuberculous mycobacterial infections. , 2004, The Annals of thoracic surgery.